Effects of long-term treatment with ranirestat, a potent aldose reductase inhibitor, on diabetic cataract and neuropathy in spontaneously diabetic torii rats

Journal of Diabetes Research

Volumn 2013, Issue , 2013, Pages

  Ota, Ayumi ^a   Kakehashi, Akihiro ^a   Toyoda, Fumihiko ^a   Kinoshita, Nozomi ^a   Shinmura, Machiko ^a   Takano, Hiroko ^a   Obata, Hiroto ^a   Matsumoto, Takafumi ^b   Tsuji, Junichi ^b   Dobashi, Yoh ^a   Fujimoto, Wilfred Y ^a,c   Kawakami, Masanobu ^a   Kanazawa, Yasunori ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPALRESTAT; FRUCTOSE; HEMOGLOBIN A1C; RANIRESTAT; SORBITOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATARACT; CONTROLLED STUDY; DIABETIC NEUROPATHY; DISEASE COURSE; DOSE RESPONSE; HEMOGLOBIN BLOOD LEVEL; LONG TERM CARE; MOTOR NERVE CONDUCTION; NONHUMAN; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SPONTANEOUSLY DIABETIC TORII RAT; TREATMENT DURATION;

EID: 84879332526     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2013/175901     Document Type: Article

References (20)

1. Friedman D. S., Ali F., Kourgialis N., Diabetic retinopathy in the developing world: how to approach identifying and treating underserved populations. American Journal of Ophthalmology 2011 151 2 192.e1 194.e1 2-s2.0-78751666674 10.1016/j.ajo.2010.10.014
2. Genuth S., Lipps J., Lorenzi G., Nathan D. M., Davis M. D., Lachin J. M., Cleary P. A., Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. Journal of the American Medical Association 2002 287 19 2563 2569 2-s2.0-0037093012 (Pubitemid 34517203)
3. Reichard P., Nilsson B. Y., Rosenqvist U., The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. The New England Journal of Medicine 1993 329 5 304 309 2-s2.0-0027275397 10.1056/NEJM199307293290502 (Pubitemid 23210681)
4. Kakehashi A., Kado M., Akiba J., Hirokawa H., Variations of posterior vitreous detachment. British Journal of Ophthalmology 1997 81 7 527 532 2-s2.0-0030878694 (Pubitemid 27354922)
5. Kern T. S., Engerman R. L., Immunohistochemical distribution of aldose reductase. Histochemical Journal 1982 14 3 507 515 2-s2.0-0020316829 (Pubitemid 12059652)
6. Kawakubo K., Mori A., Sakamoto K., Nakahara T., Ishii K., GP-1447, an inhibitor of aldose reductase, prevents the progression of diabetic cataract in rats. Biological & Pharmaceutical Bulletin 2012 35 6 866 872
7. Gabbay K. H., The sorbitol pathway and the complications of diabetes. The New England Journal of Medicine 1973 288 16 831 836 2-s2.0-0015929739
8. Liang H. R., Takagaki T., Foltz R. L., Bennett P., Quantitative determination of endogenous sorbitol and fructose in human erythrocytes by atmospheric-pressure chemical ionization LC tandem mass spectrometry. Journal of Chromatography B 2005 824 1-2 36 44 2-s2.0-24044444290 10.1016/j.jchromb.2005. 05.020 (Pubitemid 41215579)
9. Jennings P. E., McLaren M., Scott N. A., Saniabadi A. R., Belch J. J. F., The relationship of oxidative stress to thrombotic tendency in Type 1 diabetic patients with retinopathy. Diabetic Medicine 1991 8 9 860 865 2-s2.0-0026049732
10. Schroder S., Palinski W., Schmid-Schonbein G. W., Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. American Journal of Pathology 1991 139 1 81 100 2-s2.0-0025769620
11. Chibber R., Molinatti P. A., Rosatto N., Lambourne B., Kohner E. M., Toxic action of advanced glycation end products on cultured retinal capillary pericytes and endothelial cells: relevance to diabetic retinopathy. Diabetologia 1997 40 2 156 164 2-s2.0-0031019299 10.1007/s001250050657 (Pubitemid 27060287)
12. Kern T. S., Engerman R. L., Distribution of aldose reductase in ocular tissues. Experimental Eye Research 1981 33 2 175 182 2-s2.0-0019501225 (Pubitemid 11039561)
13. Robison W. G. Jr., Kador P. F., Kinoshita J. H., Retinal capillaries: basement membrane thickening by galactosemia prevented with aldose reductase inhibitor. Science 1983 221 4616 1177 1179 2-s2.0-0020604667 (Pubitemid 13001229)
14. Yeh L. A., Rafford C. E., Beyer T. A., Hutson N. J., Effects of the aldose reductase inhibitor sorbinil on the isolated cultured rat lens. Metabolism 1986 35 4, supplement 1 4 9 2-s2.0-46149138145 (Pubitemid 16104315)
15. Hennekens C., A randomized trial of sorbinil, an aldose reductase inhibitor, in diabetic retinopathy. Archives of Ophthalmology 1990 108 9 1234 1244 2-s2.0-0025073693 (Pubitemid 20295382)
16. Kakehashi A., Takezawa M., Toyoda F., Aldose reductase inhibitor fidarestat prevents diabetic ocular complications in spontaneously diabetic Torii rats. The Open Diabetes Journal 2011 4 101 107
17. Kakehashi A. O., Ota A., Toyoda F., Kinoshita N., Ola M. S., Prophylactic medical treatment of diabetic retinopathy. Diabetic Retinopathy 2012 Rijeka, Croatia InTech 291 304
18. Matsumoto T., Ono Y., Kuromiya A., Toyosawa K., Ueda Y., Bril V., Long-term treatment with ranirestat (AS-3201), a potent aldose reductase inhibitor, suppresses diabetic neuropathy and cataract formation in rats. Journal of Pharmacological Sciences 2008 107 3 340 348 2-s2.0-47749146137 10.1254/jphs.08071FP (Pubitemid 352030321)
19. Shinohara M., Masuyama T., Shoda T., Takahashi T., Katsuda Y., Komeda K., Kuroki M., Kakehashi A., Kanazawa Y., A new spontaneously diabetic non-obese torii rat strain with severe ocular complications. Experimental Diabesity Research 2000 1 2 89 100 2-s2.0-0034570430
20. Ao S., Kikuchi C., Ono T., Notsu Y., Effect of instillation of aldose reductase inhibitor FR74366 on diabetic cataract. Investigative Ophthalmology and Visual Science 1991 32 12 3078 3083 2-s2.0-0025995372